Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation

An Open-Label, Single-Arm Pilot Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device Used to Reduce Mitral Regurgitation

Improvement in heart failure with moderate to severe mitral regurgitation using a percutaneously delivered implanted device

Inclusion Criteria:

• Symptomatic heart failure
• functional MR 2+ - 4+
• LVEF 20% - 50%

Exclusion Criteria:

• MR of organic origins
• significant co-morbidities